Comment on “Management of Atrial Fibrillation in Critically Ill Patients”

Comment on “Management of Atrial Fibrillation in Critically Ill Patients”

Bibliographic Details
Main Author:	Roger Jelliffe
Format:	Article
Language:	English
Published:	Hindawi Limited 2016-01-01
Series:	Critical Care Research and Practice
Online Access:	http://dx.doi.org/10.1155/2016/8985161

Similar Items

Comment on “Management of Atrial Fibrillation in Critically Ill Patients”
by: Sébastien Champion
Published: (2015-01-01)

Response to: Comment on “Management of Atrial Fibrillation in Critically Ill Patients”
by: Mattia Arrigo, et al.
Published: (2016-01-01)

Management of Atrial Fibrillation in Critically Ill Patients
by: Mattia Arrigo, et al.
Published: (2014-01-01)

Prognosis and management of new‐onset atrial fibrillation in critically ill patients
by: Jun Qian, et al.
Published: (2021-05-01)

New-Onset Atrial Fibrillation in Critically Ill Patients
by: Stephanie Sibley, et al.
Published: (2015-01-01)

Atrial Fibrillation Prediction from Critically Ill Sepsis Patients
by: Syed Khairul Bashar, et al.
Published: (2021-08-01)

Managing new-onset atrial fibrillation in critically ill patients: a systematic narrative review
by: Oliver C Redfern, et al.
Published: (2020-03-01)

Comment on “Disease management: Atrial fibrillation and home monitoring”
by: Daniel Ferreira
Published: (2014-07-01)

High-Sensitivity Estimate of the Incidence of New-Onset Atrial Fibrillation in Critically Ill Patients
by: William F. McIntyre, MD, et al.
Published: (2021-01-01)

Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients
by: Alain Rudiger, et al.
Published: (2014-01-01)

Current practice in the management of new-onset atrial fibrillation in critically ill patients: a UK-wide survey
by: Chung Shen Chean, et al.
Published: (2017-09-01)

Comment on «Subclinical atrial fibrillation and the risk of stroke»
by: Diogo Magalhães Cavaco
Published: (2012-05-01)

Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients
by: Geoffroy Hariri, et al.
Published: (2021-01-01)

Factors Associated with the Incidence and Severity of New-Onset Atrial Fibrillation in Adult Critically Ill Patients
by: Péricles A. D. Duarte, et al.
Published: (2017-01-01)

Evaluation of Amiodarone Use for New-Onset Atrial Fibrillation in Critically Ill Patients With Septic Shock
by: Betthauser, K.D, et al.
Published: (2021)

New‐onset atrial fibrillation in critically ill patients with coronavirus disease 2019 (COVID‐19)
by: Bişar Ergün, et al.
Published: (2021-10-01)

COMMENTS ON THE EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION (2010)
by: V. A. Sulimov
Published: (2016-01-01)

Effect of acceptance of illness on treatment adherence in atrial fibrillation patients
by: Andrzej Martynow, et al.
Published: (2017-05-01)

Comorbidity in elderly patients with atrial fibrillation affects the “cost of illness”
by: S. V. Malchikova, et al.
Published: (2019-10-01)

Amikacin Population Pharmacokinetics in Critically Ill Kuwaiti Patients
by: Kamal M. Matar, et al.
Published: (2013-01-01)

Corrigendum to “Factors Associated with the Incidence and Severity of New-Onset Atrial Fibrillation in Adult Critically Ill Patients”
by: Péricles A. D. Duarte, et al.
Published: (2019-01-01)

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
by: Trigo P, et al.
Published: (2011-12-01)

Comment on “Atrial fibrillation in myocardial infarction patients: Impact on health care utilization”
by: António Jorge Jara
Published: (2014-04-01)

Risk prediction of clinical adverse outcomes with machine learning in a cohort of critically ill patients with atrial fibrillation
by: Lorenzo Falsetti, et al.
Published: (2021-09-01)

Burden of disease and cost of illness of atrial fibrillation in Portugal
by: Miguel Gouveia, et al.
Published: (2015-01-01)

Comment on “Stroke Prevention in Atrial Fibrillation: A Systematic Review”
by: Evangelista Rocha
Published: (2015-07-01)

Comment on «Stroke and bleeding in atrial fibrillation with chronic kidney disease»
by: Carlos Aguiar
Published: (2012-12-01)

Endocrine emergencies in critically-ill patients: Challenges in diagnosis and management: Comment
by: Preeti Shanbag
Published: (2013-01-01)

Management of atrial fibrillation
by: Puneet Kakar, et al.
Published: (2007-03-01)

Comment on “Surgical ablation of atrial fibrillation during mitral‐valve surgery”
by: Diogo Magalhães Cavaco
Published: (2016-04-01)

How to Manage Atrial Fibrillation in the Emergency Department: a Critical Appraisal
by: Rafael Thiesen Magliari, et al.
Published: (2020-06-01)

Electrocardiographic risk factors of new-onset atrial fibrillation among critically ill patients with sepsis: a case-referent study
by: Ambrus, Daniel Balint
Published: (2017)

Updated Management of Atrial Fibrillation
by: Mehmet Ergin, et al.
Published: (2015-09-01)

Atrial Fibrillation: Mechanisms and Management
by: Tong Liu, et al.
Published: (2019-01-01)

Dronedarone in the management of atrial fibrillation
by: TS Mohamed Saleem, et al.
Published: (2010-03-01)

Evaluation of atrial fibrillation management and cardiovascular risk profile in atrial fibrillation patients: A cross-sectional survey
by: Gediminas Račkauskas, et al.
Published: (2017-01-01)

Comment on “Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting”
by: Luís Silva Miguel
Published: (2015-11-01)

Reply to the comment: With regard to the implementation of the AGREE instrument in Atrial Fibrillation Clinical Guidelines
by: José Kelvin Galvez-Olortegui, et al.
Published: (2016-03-01)

Cost of illness of atrial fibrillation: a nationwide study of societal impact
by: Søren Paaske Johnsen, et al.
Published: (2017-11-01)

Change in Atrial Fibrillation Burden over Time in Patients with Nonpermanent Atrial Fibrillation
by: Philipp Krisai, et al.
Published: (2020-01-01)